Nuveen Asset Management, LLC Sight Sciences, Inc. Transaction History

Nuveen Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.88 - $8.8 $90,443 - $276,355	-31,404 Reduced 21.43%	115,145 $388,000
Q2 2023 Aug 14, 2023	BUY	$7.46 - $10.67 $134,429 - $192,273	18,020 Added 14.02%	146,549 $1.21 Million
Q1 2023 May 15, 2023	BUY	$8.44 - $13.35 $214,089 - $338,636	25,366 Added 24.59%	128,529 $1.12 Million
Q4 2022 Feb 14, 2023	BUY	$5.58 - $13.94 $69,471 - $173,553	12,450 Added 13.72%	103,163 $1.26 Million
Q3 2022 Nov 14, 2022	SELL	$6.1 - $11.41 $7,435 - $13,908	-1,219 Reduced 1.33%	90,713 $577,000

Q2 2022 Aug 15, 2022	BUY	$6.61 - $11.99 $343,964 - $623,923	52,037 Added 130.43%	91,932 $826,000
Q1 2022 May 16, 2022	BUY	$11.56 - $17.9 $295,693 - $457,864	25,579 Added 178.67%	39,895 $599,000
Q3 2021 Nov 12, 2021	BUY	$22.34 - $39.1 $319,819 - $559,755	14,316 New	14,316 $327,000

21.1M

33.2K

27.7K

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $296M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.